Adcock calls for rise in South African SEP

South Africa’s Adcock Ingram says it is “engaging constructively” with the Pricing Committee of the country’s National Department of Health to see if any “short-term relief” will be available on the country’s single exit price (SEP), amidst “concern” over the recent fall in the value of the rand and rising costs at the company.